THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain cancer known for its rapid growth and resistance to conventional treatments. Investigations are constantly underway to identify new therapeutic strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for GBM treatment. LCA168 is a protein that is overexpressed in glioblastoma cells